A Two-year Study of Telbivudine in HBeAg Negative Hepatitis

NCT01521975 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

360

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: Telbivudine, Adefovir dipivoxil

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University

Collaborators

[object Object]
[object Object]